Cargando…
Effectiveness of convalescent plasma therapy in a patient with severe COVID-19-associated acute kidney injury
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. Recent findings indicate an increased risk for kidney involvement, including progressive acute kidney injury (AKI) during COVID-1...
Autores principales: | Brener, Zachary Z., Brenner, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170122/ https://www.ncbi.nlm.nih.gov/pubmed/34084692 http://dx.doi.org/10.5414/CNCS110507 |
Ejemplares similares
-
Convalescent plasma therapy in obese severe COVID-19 adolescents: Two cases report
por: Cesilia, Citra, et al.
Publicado: (2021) -
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
por: Duan, Kai, et al.
Publicado: (2020) -
Efficacy of convalescent plasma therapy in severe COVID-19 patients
por: Akay Cizmecioglu, Hilal, et al.
Publicado: (2021) -
Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
por: Das, Santa Kumar, et al.
Publicado: (2021) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021)